HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Tan Selected Research

Pyruvic Acid (Pyruvate)

3/2019p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
5/2016Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation.
1/2015The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Tan Research Topics

Disease

69Neoplasms (Cancer)
12/2023 - 05/2002
43Infections
01/2024 - 11/2004
36Breast Neoplasms (Breast Cancer)
12/2022 - 05/2002
16Neoplasm Metastasis (Metastasis)
01/2023 - 11/2004
16Gastroenteritis
01/2022 - 06/2005
12Diarrhea
02/2024 - 05/2012
8Nasopharyngeal Carcinoma
01/2023 - 12/2007
7Leukemia
07/2019 - 08/2003
7Pain (Aches)
06/2014 - 03/2009
6Inflammation (Inflammations)
06/2023 - 08/2007
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 08/2009
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2019 - 08/2003
5Carcinogenesis
01/2017 - 08/2009
4Decapitation
06/2023 - 04/2018
4Rotavirus Infections
05/2023 - 11/2019
4Squamous Cell Carcinoma of Head and Neck
01/2023 - 04/2012
4Lymphatic Metastasis
12/2022 - 02/2015
4Thrombosis (Thrombus)
10/2022 - 01/2016
4Human Influenza (Influenza)
01/2022 - 12/2004
4Caliciviridae Infections
07/2015 - 06/2005
4Hyperalgesia
10/2011 - 08/2007
3Alzheimer Disease (Alzheimer's Disease)
01/2024 - 05/2017
3Cognitive Dysfunction
01/2024 - 01/2020
3Chlamydia Infections
01/2021 - 04/2009
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 02/2004
3Head and Neck Neoplasms (Head and Neck Cancer)
09/2014 - 09/2008
3Knee Osteoarthritis
06/2014 - 03/2009
2Atherosclerosis
02/2024 - 06/2017
2Obstructive Sleep Apnea
01/2024 - 01/2023
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2023 - 10/2022
2Malaria
10/2023 - 01/2017
2Virus Diseases (Viral Diseases)
05/2023 - 06/2014
2Chronic Disease (Chronic Diseases)
12/2022 - 01/2018
2COVID-19
10/2021 - 01/2021
2Neuralgia (Stump Neuralgia)
11/2020 - 09/2011

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2024 - 08/2003
22Blood Group Antigens (Blood Groups)IBA
12/2022 - 06/2005
20VaccinesIBA
02/2024 - 02/2008
12Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2008
11Paclitaxel (Taxol)FDA LinkGeneric
12/2022 - 02/2009
10MicroRNAs (MicroRNA)IBA
01/2023 - 07/2010
8Glucose (Dextrose)FDA LinkGeneric
08/2017 - 01/2011
7Antiviral Agents (Antivirals)IBA
01/2024 - 02/2008
7Polysaccharides (Glycans)IBA
01/2021 - 10/2017
6RNA (Ribonucleic Acid)IBA
06/2023 - 08/2002
6Trastuzumab (Herceptin)FDA Link
12/2022 - 08/2004
6salicylhydroxamic acid (SHAM)IBA
01/2016 - 06/2010
5Indicators and Reagents (Reagents)IBA
02/2024 - 10/2004
5Rotavirus VaccinesIBA
05/2023 - 01/2019
5Phosphotransferases (Kinase)IBA
01/2023 - 02/2006
5Docetaxel (Taxotere)FDA Link
12/2022 - 12/2009
5LigandsIBA
01/2021 - 03/2014
5DNA (Deoxyribonucleic Acid)IBA
02/2016 - 02/2003
5Peptides (Polypeptides)IBA
03/2015 - 04/2006
4Transcription Factors (Transcription Factor)IBA
02/2024 - 01/2015
4AntigensIBA
01/2023 - 11/2004
4Messenger RNA (mRNA)IBA
01/2022 - 08/2003
4Lactate Dehydrogenase 5IBA
03/2019 - 02/2010
4Immune Sera (Antisera)IBA
11/2018 - 01/2014
4Fluorouracil (Carac)FDA LinkGeneric
04/2012 - 08/2002
3CytokinesIBA
01/2023 - 10/2021
3Mitochondrial DNA (mtDNA)IBA
01/2023 - 01/2016
3InterferonsIBA
01/2023 - 01/2021
3pertuzumabIBA
12/2022 - 01/2017
3Carboplatin (JM8)FDA LinkGeneric
12/2022 - 03/2013
3Long Noncoding RNAIBA
01/2022 - 01/2014
3Hormones (Hormone)IBA
10/2021 - 05/2008
3Therapeutic UsesIBA
01/2021 - 05/2012
3Protein Isoforms (Isoforms)IBA
02/2020 - 09/2014
3Pyruvic Acid (Pyruvate)IBA
03/2019 - 01/2015
3Lactic Acid (Lactate)FDA LinkGeneric
03/2019 - 01/2015
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 11/2004
3Drug CombinationsIBA
06/2017 - 07/2008
3Small Interfering RNA (siRNA)IBA
01/2015 - 05/2009
3Etoposide (VP 16)FDA LinkGeneric
04/2013 - 03/2005
3Cytarabine (Cytosar-U)FDA LinkGeneric
04/2013 - 03/2005
3Cisplatin (Platino)FDA LinkGeneric
04/2012 - 12/2009
3Freund's AdjuvantIBA
11/2011 - 08/2007
2Complement System Proteins (Complement)IBA
01/2024 - 01/2023
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2024 - 01/2023
2Sunitinib (Sutent)FDA Link
11/2023 - 10/2022
2ripretinibIBA
11/2023 - 10/2022
2Imatinib Mesylate (Gleevec)FDA Link
11/2023 - 10/2022
2Immune Checkpoint ProteinsIBA
01/2023 - 01/2017
2EnzymesIBA
01/2023 - 03/2019
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2023 - 12/2020
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2022
2crofelemer (SP-303)IBA
12/2022 - 01/2017
2CytokininsIBA
10/2022 - 10/2018
2Influenza Vaccines (Influenza Vaccine)FDA Link
01/2022 - 10/2011
2N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2021 - 05/2012
2Sialic AcidsIBA
12/2021 - 07/2015
2human ERBB2 proteinIBA
10/2021 - 01/2017
2Immunoglobulin G (IgG)IBA
01/2021 - 08/2012

Therapy/Procedure

36Therapeutics
10/2023 - 08/2002
12Drug Therapy (Chemotherapy)
12/2023 - 09/2008
5Electroacupuncture
11/2011 - 08/2007
3Lasers (Laser)
07/2019 - 03/2009
3Induction Chemotherapy
04/2012 - 12/2009
2Aftercare (After-Treatment)
10/2022 - 10/2018